Delivery Order SPE2DB20D1100-SPE2DB25FD9M6
Award Date 8/8/25
Potential Completion Date 8/11/25
Potential Value $8.4K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $36,330.77 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units of use on August 7, 2025, with completion targeted for August 8, 2025. This firm fixed-price contract represents a non-competitive delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026....
- The Defense Logistics Agency awarded a delivery order valued at $19,065.20 to AmerisourceBergen Drug Corp for Emverm 100 mg tablet chewable units. This non-competitive, firm fixed-price delivery order was issued on July 21, 2025, with an ultimate completion date of July 22, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Emverm 100 mg tablet chewable units of use, with a ceiling value of $7,266.59. This competitively awarded, firm fixed-price delivery order is set to conclude by August 8, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was awarded through open competition based on...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 5, 2025, for the supply of Emverm 100 mg tablet chewables, with a ceiling value of $32,123.06. The contract is structured as a firm fixed price delivery order with an ultimate completion date of August 6, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This award utilized no set-aside designation and was competitively awarded to the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide EMVERM 100 MG TABLET CHEW UDS pharmaceutical products. The $21,387.17 contract has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract awarded by DLA to AmerisourceBergen Drug Corp valued at...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor, for the supply of EMVERM 100 MG TABLET CHEW UDS. The order, valued at $33,296.99, is a firm fixed-price contract with an ultimate completion date of August 19, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a...
- This federal contract award, with ID SPE2DB22D2007|SPE2DB25FJ0ZY, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,213.77 firm fixed-price delivery order is for the supply of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract has an ultimate completion date of April 28, 2025 and was awarded on April 25, 2025. It is not a set-aside contract, indicating open...
- This is a $28,668.83 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of EMVERM 100 mg chewable tablets. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999, which enables DLA to efficiently procure a comprehensive range of medical commodities, including prescription drugs and medical supplies, to support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,383.49, is for the delivery of EMVERM 100 MG TABLET CHEW UDS, a pharmaceutical product. The contract is a firm fixed-price, non-set-aside award with a completion date of June 18, 2025. Amerisourcebergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This federal contract award, valued at $4,747.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for the supply of EMVERM 100 MG TABLET CHEW UDS, a medical product, with a period of performance through May 1, 2025. The award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...